What MediZap does

MediZap is a private U.S. service provider that delivers E-Beam (electron beam) and X-Ray terminal sterilization for compounded pharmaceuticals, targeting 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies across North America (and selectively South America). The company's core service is radiation-based terminal sterilization using beta and photon radiation to achieve a sterility assurance level of 10⁻⁶, with a 2-business-day turnaround that the company positions against the 5-8 business day standard for gamma sterilization. Underlying capacity is provided through an exclusive partnership with Steri-Tek, which operates the accelerator infrastructure.

MediZap packages its offering as a "Four Pillar Service": (1) E-Beam/X-Ray sterilization, (2) proprietary packaging solutions (Medi-Packs single-use primary packaging, Steri-Packs multi-use secondary packaging, Disperse-Packs single-use secondary packaging, plus 2:1 and 3:1 custom labels with integrated irradiation indicators), (3) compliance support covering FDA, USP (<797>, <800>), DEA, SPB, and ISO frameworks, and (4) exclusive partnerships with Pacific BioLabs (ISO testing/validation), Element Materials Technology (analytical chemistry and sterility testing), Complete Group Services (a GSO for compounding), and kadara medical (trocar devices). The pre-validated packaging and dosimetry profile function as a switching-cost mechanism.

The business model combines usage-based sterilization fees, hardware/physical product sales (packaging and labels), and professional services (compliance and consulting). Pricing is quote-based and not publicly disclosed. MediZap is a California LLC (Medizap LLC), co-founded and controlled by Jonathan Bergstrom (CEO) and Nicole Bergstrom (COO), with no disclosed institutional investors or parent company. The company operates from Loomis, California, with 11-50 employees, and runs a content-driven marketing program (webinars, newsletter, blog) to build category authority in the compounding pharmaceutical sterilization niche.

Name

MediZap

Legal name

Medizap LLC

Website

https://medizap.co

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

MediZap is a private U.S. service provider that delivers E-Beam and X-Ray terminal sterilization, proprietary packaging, and compliance support to 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies across North America through exclusive partnerships.

Ownership category

akta.pro rank

Product category

Pharmaceutical Sterilization Services

NAICS

Medical Equipment and Supplies Manufacturing (3391)

akta.pro primary industry

Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers) (HLAHANAB)

akta.pro secondary industries

Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers) (HLAHANAC), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

Keywords

• Terminal sterilization services
• E-beam sterilization
• X-ray irradiation
• Compounding pharmacy services
• Sterile pharmaceutical packaging

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Terminal Sterilization Services: E-Beam and X-Ray terminal sterilization services for compounded pharmaceuticals, offering fastest turnaround times (2 business days vs. 5-8 days for Gamma), dedicated capacity, and highest sterility assurance level of 10⁻⁶.
2. Packaging Solutions: Primary and secondary packaging solutions including Medi-Packs (single-use), Steri-Packs (multi-use), and Disperse-Packs (single-use secondary packaging), along with custom labeling solutions using NiceLabel software and Cab Squix printers.
3. Compliance Services: Document control, regulatory audit preparation support, and compliance advisement for FDA, USP, SPB, and DEA requirements.
4. Exclusive Partnership Services: Integrated services through exclusive partnerships including validation services, sterile compounding testing, and consulting support.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

MediZap delivers E-Beam and X-Ray terminal sterilization services for compounded pharmaceuticals at partner Steri-Tek's ISO 13485/ISO 11137 accredited facilities, achieving a 10⁻⁶ sterility assurance level with a 2-business-day turnaround. Its Four Pillar Service bundles that sterilization with pre-validated primary and secondary packaging (Medi-Packs, Steri-Packs, Disperse-Packs), custom labeling, FDA/USP/DEA/SPB compliance support, and exclusive CRO/GSO partnerships for 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical manufacturers across North and South America.

Product overview

MediZap offers a unified Four Pillar Service platform for compounded pharmaceutical sterilization. The core service is E-Beam | X-Ray terminal sterilization, which integrates with proprietary packaging solutions (Medi-Packs, Steri-Packs, Disperse-Packs) and labeling solutions (2:1 and 3:1 Labels). Supporting modules include cold chain logistics and compliance support. The company positions itself as North America's premier turn-key service provider for electron beam and X-ray sterilization serving compounding pharmacies and pharmaceutical manufacturers across North America.

Differentiator

Problem solved

Functional benefit

Brands

• STERI-PACK INNOVATIONS: MediZap's research and development team created next generation secondary packaging for 30ml, 50ml & 100ml vial solutions.
• MEDI-PACKS
• STERI-PACKS
• DISPERSE-PACKS

Products and services

• E-Beam | X-Ray Sterilization Advanced electron beam and X-ray terminal sterilization services for compounded pharmaceuticals, delivered through partner Steri-Tek's ISO 13485 and ISO 11137 accredited facility with 10⁻⁶ sterility assurance and a 2-business-day turnaround versus 5–8 business days for Gamma sterilization. Built for sterile drug manufacturers and designed as a Compounding Center of Excellence with dedicated capacity and no reservation requirements.
• Medi-Packs Single-use primary packaging for validated drug products, including blister packs, vials, and caps, validated specifically for Electron-Beam processing with built-in color irradiation indicators. Bundled and unitized for easy ordering.
• Steri-Packs Multi-use secondary packaging solutions for terminal sterilization via E-Beam/X-Ray technology, protecting products with custom multi-layer high-density foam. Available in Standard (2ml–10ml vials), Tall (30ml–100ml vials), and Cold variants. Includes MediZap Steri-Pack Innovations next-generation secondary packaging for 30ml, 50ml, and 100ml vial solutions.
• Disperse-Packs Single-use secondary packaging for the transfer of product from sterilization packaging to fulfillment-ready solutions, accommodating various vial sizes and ophthalmic droppers.
• Compliance Support Document control, regulatory audit preparation, and compliance advisement for compounding pharmacies and pharmaceutical manufacturers against ISO 11137 + 11737, IOH, FDA, USP, SPB, and DEA requirements. Includes guidance on USP <797>, USP <800>, and cGMP compliance delivered through a multi-layered quality control team.

Quantifiable outcome

• 2 business day turnaround vs. 5-8 business days for Gamma sterilization
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and strategic.

• Steri-TekcoreTechnology or IntegrationMediZap is an exclusive partner to SteriTek for all terminal sterilization with dedicated capacity for customers. SteriTek operates the most advanced accelerators for high and low volume E-Beam | X-Ray terminal sterilization. The facility is accredited to ISO 13485 and ISO 11137, with DEA licenses for controlled substances. The partnership provides full process validated sterilized drug product without costly setup and processing fees.
• Pacific BioLabscoreTechnology or IntegrationPacific BioLabs is a contract research organization (CRO) exclusively partnered with MediZap for ISO testing and validations supporting new product sterilization validations and ongoing process validations. Specializing in biological sciences with cGMP and GLP compliance and ISO 17025 accreditation. Located in San Francisco Bay Area for close support to Steri-Tek.
• Element Materials Technology (Element)coreTechnology or IntegrationExclusive partnership integrating Element's sterile compounding testing services, analytical chemistry, environmental monitoring, and USP <797>, USP <800>, and cGMP FDA compliance expertise into MediZap's Four Pillar Service. Services include peel off sample submission, Q-Alerts quality investigations, and advanced testing technologies including Rapid Sterility USP <1223> BacT | ALERT®.
• Complete Group Services (CGS)coreStrategic or Co-development PartnerComplete Group Services is the first and only GSO created for compounding and manufacturing of pharmaceutical products. Partnership adds benefits including Marketing and Consulting Support, Vendor Contracts, and Consolidated Points of Contact. Free membership for 503A compounding pharmacies and 503B outsourcing facilities through MediZap.
• kadara™ medicalstrategicStrategic or Co-development Partnerkadara™ medical sets the gold standard for FDA registered American manufacturer of pellet therapy trocar devices and trocar kits. Utilizes the same E-beam sterilization technology from MediZap's exclusive partner SteriTek. Offers exclusive pricing and customer support to MediZap customers for medical practitioners.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Steri-Tek: Steri-Tek operates E-Beam and X-Ray contract sterilization facilities and is MediZap's exclusive capacity partner. It is directly comparable as a provider of high-energy terminal sterilization services for pharma and medical devices, and is the most natural direct competitor should it choose to sell directly to compounders.
• E-BEAM Services: E-BEAM Services operates contract electron-beam sterilization facilities in the U.S. for medical devices and pharmaceutical products. It is a direct E-Beam peer using the same underlying technology modality that MediZap packages into its compounding-pharma offering.

Broad incumbents

• Sterigenics (Sotera Health): Sterigenics is the largest global contract sterilization provider, predominantly Gamma and EtO, serving pharma, medical device, and food customers. It is the incumbent benchmark MediZap references (5–8 day Gamma turnaround) and represents the most significant competitive force in terminal sterilization.
• STERIS: STERIS is a global leader in sterilization and infection prevention products and contract sterilization services. It competes broadly across sterilization modalities and serves many of the same pharma and medical-device customers MediZap targets.
• Cantel Medical (now part of STERIS): Cantel provides contract sterilization and infection-prevention services for medical devices and life-science products. Comparable as a multi-modality sterilization services vendor serving healthcare-adjacent manufacturers.
• Getinge: Getinge offers sterilization equipment and contract sterilization services across pharma and healthcare. It is comparable as a large incumbent with multi-modality sterilization capabilities serving sterile manufacturing customers.

Emerging players

• Noxilizer: Noxilizer provides nitrogen dioxide terminal sterilization services aimed at pharma, biotech and medical devices. It competes in the same 'alternatives to Gamma' lane as MediZap and targets customers seeking faster, lower-temperature sterilization options.
• Bioquell (Ecolab): Bioquell specializes in bio-decontamination using hydrogen peroxide vapor for pharma compounding and cleanroom environments. It overlaps with MediZap in serving 503A/503B contamination-control needs, particularly around USP <797>/<800> compliance.

Regional players

• Fagron: Fagron is a leading supplier of pharmaceutical raw materials, equipment and services to compounding pharmacies globally. It is comparable because MediZap's customers are Fagron's buyers; both compete for share of the 503A/503B wallet.
• PCCA (Professional Compounding Centers of America): PCCA supports compounding pharmacies with APIs, equipment, training, and base formulations across North America. It targets the same 503A customer base MediZap addresses and is referenced in MediZap's industry-conference outreach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/medizap

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediZap